BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6437506)

  • 1. Pathways to complement activation during cardiopulmonary bypass.
    Collett B; Alhaq A; Abdullah NB; Korjtsas L; Ware RJ; Dodd NJ; Alimo E; Ponte J; Vergani D
    Br Med J (Clin Res Ed); 1984 Nov; 289(6454):1251-4. PubMed ID: 6437506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation before, during and after cardiopulmonary bypass.
    Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D
    Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
    Seghaye MC; Duchateau J; Grabitz RG; Faymonville ML; Messmer BJ; Buro-Rathsmann K; von Bernuth G
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):978-87. PubMed ID: 8246580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil lysosomal enzyme release and complement activation during cardiopulmonary bypass.
    Antonsen S; Brandslund I; Clemensen S; Søfeldt S; Madsen T; Alstrup P
    Scand J Thorac Cardiovasc Surg; 1987; 21(1):47-52. PubMed ID: 3495878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative changes in complement associated with cardiopulmonary bypass.
    Boralessa H; Shifferli JA; Zaimi F; Watts E; Whitwam JG; Rees AJ
    Br J Anaesth; 1982 Oct; 54(10):1047-52. PubMed ID: 6982053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation in the adult respiratory distress syndrome following cardiopulmonary bypass.
    Lew PD; Forster A; Perrin LH; Suter S; Neidhart P; Waldvogel F; Suter PM
    Bull Eur Physiopathol Respir; 1985; 21(3):231-5. PubMed ID: 3873974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study.
    Seghaye MC; Duchateau J; Grabitz RG; Wolff T; Marcus C; Engelhardt W; Hörnchen H; Messmer BJ; von Bernuth G
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):882-92. PubMed ID: 8614150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of complement activation during bypass by prime manipulation.
    Bonser RS; Dave JR; Davies ET; John L; Taylor P; Gaya H; Lennox SC; Vergani D
    Ann Thorac Surg; 1990 Feb; 49(2):279-83. PubMed ID: 2306150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations.
    Seghaye MC; Grabitz RG; Duchateau J; Busse S; Däbritz S; Koch D; Alzen G; Hörnchen H; Messmer BJ; Von Bernuth G
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):687-97. PubMed ID: 8800157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation.
    Howard RJ; Crain C; Franzini DA; Hood CI; Hugli TE
    Arch Surg; 1988 Dec; 123(12):1496-501. PubMed ID: 3190431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of methylprednisolone on complement, immunoglobulins and pulmonary neutrophil sequestration during cardiopulmonary bypass.
    Dernek S; Tünerir B; Sevin B; Aslan R; Uyguç O; Kural T
    Cardiovasc Surg; 1999 Jun; 7(4):414-8. PubMed ID: 10430523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary bypass and complement activation. Involvement of classical and alternative pathways.
    Jones HM; Matthews N; Vaughan RS; Stark JM
    Anaesthesia; 1982 Jun; 37(6):629-33. PubMed ID: 6920244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The observation of complement activation and polymorphonuclear neutrocytopenia during cardiopulmonary bypass.
    Wang D; Fu P; Cai J; Lan H
    J Tongji Med Univ; 1996; 16(2):99-102. PubMed ID: 9275702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement (C3, C4) and C-reactive protein responses to cardiopulmonary bypass and protamine administration.
    Tulunay M; Demiralp S; Tastan S; Akalin H; Ozyurda U; Corapcioglu T; Akarsu ES
    Anaesth Intensive Care; 1993 Feb; 21(1):50-5. PubMed ID: 8447607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of C3, C3d and factor Ba in burn patients in Hong Kong Chinese.
    Wan KC; Lewis WH; Leung PC; Chien P; Hung LK
    Burns; 1998 May; 24(3):241-4. PubMed ID: 9677027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation in patients with amebic liver abscess.
    Muñoz LE; Salazar OG
    J Hepatol; 1987 Aug; 5(1):30-6. PubMed ID: 2888804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement, leukocytes, and leukocyte elastase in full-term neonates undergoing cardiac operation.
    Seghaye MC; Duchateau J; Grabitz RG; Nitsch G; Marcus C; Messmer BJ; von Bernuth G
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):29-36. PubMed ID: 8028376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation during cardiopulmonary bypass by heparin-protamine interaction.
    Best N; Sinosich MJ; Teisner B; Grudzinskas JG; Fisher MM
    Br J Anaesth; 1984 Apr; 56(4):339-43. PubMed ID: 6608952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The factors effecting complement activation in open heart surgery.
    Aslan R; Tünerir B; Dernek S; Kural T; Sevin B; Kaklikkaya I; Manti Z
    J Cardiovasc Surg (Torino); 1992; 33(6):754-60. PubMed ID: 1287017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.